Adverse Court Ruling Not To Affect Finisar’s Valuations (FNSR, DTV)

Courts have again ruled against Finisar (NASDAQ: FNSR) in its long running ‘505’ patent case against DirecTV (NYSE: DTV) and others.

Paul Bonenfant, analyst at Morgan Keegan, believes that most investors have factored in an adverse ruling and never expected Finisar obtaining a monetary reward from this case. Morgan Keegan continues to maintain its target for Finisar at $14 per share.

(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.